Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03340506
Title Dabrafenib and/or Trametinib Rollover Study
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA | NLD | FRA | ESP | DEU | AUT


No variant requirements are available.